Market Runner: Petmed Express Inc Sets 52-Week High; Strong Momentum for Holders

Market Runner: Petmed Express Inc Sets 52 Week High; Strong Momentum for Holders

The stock of Petmed Express Inc (NASDAQ:PETS) hit a new 52-week high and has $24.18 target or 7.00% above today’s $22.60 share price. The 6 months bullish chart indicates low risk for the $460.11M company. The 1-year high was reported on Dec, 1 by Barchart.com. If the $24.18 price target is reached, the company will be worth $32.21M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 3.53% or $0.77 during the last trading session, hitting $22.6. About 491,454 shares traded hands or 139.56% up from the average. Petmed Express Inc (NASDAQ:PETS) has risen 19.95% since April 28, 2016 and is uptrending. It has outperformed by 14.02% the S&P500.

Analysts await Petmed Express Inc (NASDAQ:PETS) to report earnings on January, 23. They expect $0.24 EPS, 0.00% or $0.00 from last year’s $0.24 per share. PETS’s profit will be $4.89 million for 23.54 P/E if the $0.24 EPS becomes a reality. After $0.24 actual EPS reported by Petmed Express Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Petmed Express Inc (NASDAQ:PETS) Ratings Coverage

Out of 2 analysts covering Petmed Express Inc (NASDAQ:PETS), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Petmed Express Inc has been the topic of 2 analyst reports since February 4, 2016 according to StockzIntelligence Inc. On Monday, May 9 the stock rating was upgraded by Craig Hallum to “Hold”. The stock of Petmed Express Inc (NASDAQ:PETS) has “Underperform” rating given on Thursday, February 4 by Credit Suisse.

According to Zacks Investment Research, “Petmed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.”

Insitutional Activity: The institutional sentiment increased to 1.03 in Q2 2016. Its up 0.15, from 0.88 in 2016Q1. The ratio improved, as 17 funds sold all Petmed Express Inc shares owned while 51 reduced positions. 19 funds bought stakes while 41 increased positions. They now own 14.80 million shares or 6.13% less from 15.76 million shares in 2016Q1.
Ny State Common Retirement Fund, a New York-based fund reported 20,700 shares. Symons Mngmt Inc holds 0.05% or 10,365 shares in its portfolio. First Advsrs Lp last reported 17,362 shares in the company. Barclays Public Ltd Company has invested 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS). Lsv Asset has 826,255 shares for 0.03% of their US portfolio. Northern has 268,653 shares for 0% of their US portfolio. Moreover, Manufacturers Life Co The has 0% invested in Petmed Express Inc (NASDAQ:PETS) for 14,806 shares. Us National Bank De accumulated 1,600 shares or 0% of the stock. Ls Ltd Com last reported 0% of its portfolio in the stock. Jpmorgan Chase And has 81,166 shares for 0% of their US portfolio. Pnc Gru last reported 1,925 shares in the company. Moreover, Philadelphia Company has 0.12% invested in Petmed Express Inc (NASDAQ:PETS) for 76,024 shares. Dimensional Fund Advsrs Limited Partnership accumulated 518,199 shares or 0.01% of the stock. Federated Investors Pa owns 665 shares or 0% of their US portfolio. Park Circle last reported 30,000 shares in the company.

Insider Transactions: Since August 8, 2016, the stock had 0 insider buys, and 11 selling transactions for $2.14 million net activity. $217,500 worth of Petmed Express Inc (NASDAQ:PETS) was sold by FORMICA FRANK J. 8,000 Petmed Express Inc (NASDAQ:PETS) shares with value of $163,040 were sold by ROSENBLOOM BRUCE S. AKDAG MENDERES had sold 10,000 shares worth $207,500. The insider SCHWEITZER ROBERT C sold $92,355.

Another recent and important Petmed Express Inc (NASDAQ:PETS) news was published by Quotes.Wsj.com which published an article titled: “News PetMed Express Inc.PETS” on February 12, 2011.

PETS Company Profile

PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, incorporated on January 3, 1997, is a pet pharmacy. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Firm offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment